Cargando…

An investigation of the predictors of photoprotection and UVR dose to the face in patients with XP: a protocol using observational mixed methods

INTRODUCTION: Xeroderma pigmentosum (XP) is a rare genetic condition caused by defective nucleotide excision repair and characterised by skin cancer, ocular and neurological involvement. Stringent ultraviolet protection is the only way to prevent skin cancer. Despite the risks, some patients’ photop...

Descripción completa

Detalles Bibliográficos
Autores principales: Walburn, Jessica, Sarkany, Robert, Norton, Sam, Foster, Lesley, Morgan, Myfanwy, Sainsbury, Kirby, Araújo-Soares, Vera, Anderson, Rebecca, Garrood, Isabel, Heydenreich, Jakob, Sniehotta, Falko F, Vieira, Rute, Wulf, Hans Christian, Weinman, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5724163/
https://www.ncbi.nlm.nih.gov/pubmed/28827277
http://dx.doi.org/10.1136/bmjopen-2017-018364
_version_ 1783285312872513536
author Walburn, Jessica
Sarkany, Robert
Norton, Sam
Foster, Lesley
Morgan, Myfanwy
Sainsbury, Kirby
Araújo-Soares, Vera
Anderson, Rebecca
Garrood, Isabel
Heydenreich, Jakob
Sniehotta, Falko F
Vieira, Rute
Wulf, Hans Christian
Weinman, John
author_facet Walburn, Jessica
Sarkany, Robert
Norton, Sam
Foster, Lesley
Morgan, Myfanwy
Sainsbury, Kirby
Araújo-Soares, Vera
Anderson, Rebecca
Garrood, Isabel
Heydenreich, Jakob
Sniehotta, Falko F
Vieira, Rute
Wulf, Hans Christian
Weinman, John
author_sort Walburn, Jessica
collection PubMed
description INTRODUCTION: Xeroderma pigmentosum (XP) is a rare genetic condition caused by defective nucleotide excision repair and characterised by skin cancer, ocular and neurological involvement. Stringent ultraviolet protection is the only way to prevent skin cancer. Despite the risks, some patients’ photoprotection is poor, with a potentially devastating impact on their prognosis. The aim of this research is to identify disease-specific and psychosocial predictors of photoprotection behaviour and ultraviolet radiation (UVR) dose to the face. METHODS AND ANALYSIS: Mixed methods research based on 45 UK patients will involve qualitative interviews to identify individuals’ experience of XP and the influences on their photoprotection behaviours and a cross-sectional quantitative survey to assess biopsychosocial correlates of these behaviours at baseline. This will be followed by objective measurement of UVR exposure for 21 days by wrist-worn dosimeter and daily recording of photoprotection behaviours and psychological variables for up to 50 days in the summer months. This novel methodology will enable UVR dose reaching the face to be calculated and analysed as a clinically relevant endpoint. A range of qualitative and quantitative analytical approaches will be used, reflecting the mixed methods (eg, cross-sectional qualitative interviews, n-of-1 studies). Framework analysis will be used to analyse the qualitative interviews; mixed-effects longitudinal models will be used to examine the association of clinical and psychosocial factors with the average daily UVR dose; dynamic logistic regression models will be used to investigate participant-specific psychosocial factors associated with photoprotection behaviours. ETHICS AND DISSEMINATION: This research has been approved by Camden and King’s Cross Research Ethics Committee 15/LO/1395. The findings will be published in peer-reviewed journals and presented at national and international scientific conferences.
format Online
Article
Text
id pubmed-5724163
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-57241632017-12-19 An investigation of the predictors of photoprotection and UVR dose to the face in patients with XP: a protocol using observational mixed methods Walburn, Jessica Sarkany, Robert Norton, Sam Foster, Lesley Morgan, Myfanwy Sainsbury, Kirby Araújo-Soares, Vera Anderson, Rebecca Garrood, Isabel Heydenreich, Jakob Sniehotta, Falko F Vieira, Rute Wulf, Hans Christian Weinman, John BMJ Open Dermatology INTRODUCTION: Xeroderma pigmentosum (XP) is a rare genetic condition caused by defective nucleotide excision repair and characterised by skin cancer, ocular and neurological involvement. Stringent ultraviolet protection is the only way to prevent skin cancer. Despite the risks, some patients’ photoprotection is poor, with a potentially devastating impact on their prognosis. The aim of this research is to identify disease-specific and psychosocial predictors of photoprotection behaviour and ultraviolet radiation (UVR) dose to the face. METHODS AND ANALYSIS: Mixed methods research based on 45 UK patients will involve qualitative interviews to identify individuals’ experience of XP and the influences on their photoprotection behaviours and a cross-sectional quantitative survey to assess biopsychosocial correlates of these behaviours at baseline. This will be followed by objective measurement of UVR exposure for 21 days by wrist-worn dosimeter and daily recording of photoprotection behaviours and psychological variables for up to 50 days in the summer months. This novel methodology will enable UVR dose reaching the face to be calculated and analysed as a clinically relevant endpoint. A range of qualitative and quantitative analytical approaches will be used, reflecting the mixed methods (eg, cross-sectional qualitative interviews, n-of-1 studies). Framework analysis will be used to analyse the qualitative interviews; mixed-effects longitudinal models will be used to examine the association of clinical and psychosocial factors with the average daily UVR dose; dynamic logistic regression models will be used to investigate participant-specific psychosocial factors associated with photoprotection behaviours. ETHICS AND DISSEMINATION: This research has been approved by Camden and King’s Cross Research Ethics Committee 15/LO/1395. The findings will be published in peer-reviewed journals and presented at national and international scientific conferences. BMJ Publishing Group 2017-08-21 /pmc/articles/PMC5724163/ /pubmed/28827277 http://dx.doi.org/10.1136/bmjopen-2017-018364 Text en © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/
spellingShingle Dermatology
Walburn, Jessica
Sarkany, Robert
Norton, Sam
Foster, Lesley
Morgan, Myfanwy
Sainsbury, Kirby
Araújo-Soares, Vera
Anderson, Rebecca
Garrood, Isabel
Heydenreich, Jakob
Sniehotta, Falko F
Vieira, Rute
Wulf, Hans Christian
Weinman, John
An investigation of the predictors of photoprotection and UVR dose to the face in patients with XP: a protocol using observational mixed methods
title An investigation of the predictors of photoprotection and UVR dose to the face in patients with XP: a protocol using observational mixed methods
title_full An investigation of the predictors of photoprotection and UVR dose to the face in patients with XP: a protocol using observational mixed methods
title_fullStr An investigation of the predictors of photoprotection and UVR dose to the face in patients with XP: a protocol using observational mixed methods
title_full_unstemmed An investigation of the predictors of photoprotection and UVR dose to the face in patients with XP: a protocol using observational mixed methods
title_short An investigation of the predictors of photoprotection and UVR dose to the face in patients with XP: a protocol using observational mixed methods
title_sort investigation of the predictors of photoprotection and uvr dose to the face in patients with xp: a protocol using observational mixed methods
topic Dermatology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5724163/
https://www.ncbi.nlm.nih.gov/pubmed/28827277
http://dx.doi.org/10.1136/bmjopen-2017-018364
work_keys_str_mv AT walburnjessica aninvestigationofthepredictorsofphotoprotectionanduvrdosetothefaceinpatientswithxpaprotocolusingobservationalmixedmethods
AT sarkanyrobert aninvestigationofthepredictorsofphotoprotectionanduvrdosetothefaceinpatientswithxpaprotocolusingobservationalmixedmethods
AT nortonsam aninvestigationofthepredictorsofphotoprotectionanduvrdosetothefaceinpatientswithxpaprotocolusingobservationalmixedmethods
AT fosterlesley aninvestigationofthepredictorsofphotoprotectionanduvrdosetothefaceinpatientswithxpaprotocolusingobservationalmixedmethods
AT morganmyfanwy aninvestigationofthepredictorsofphotoprotectionanduvrdosetothefaceinpatientswithxpaprotocolusingobservationalmixedmethods
AT sainsburykirby aninvestigationofthepredictorsofphotoprotectionanduvrdosetothefaceinpatientswithxpaprotocolusingobservationalmixedmethods
AT araujosoaresvera aninvestigationofthepredictorsofphotoprotectionanduvrdosetothefaceinpatientswithxpaprotocolusingobservationalmixedmethods
AT andersonrebecca aninvestigationofthepredictorsofphotoprotectionanduvrdosetothefaceinpatientswithxpaprotocolusingobservationalmixedmethods
AT garroodisabel aninvestigationofthepredictorsofphotoprotectionanduvrdosetothefaceinpatientswithxpaprotocolusingobservationalmixedmethods
AT heydenreichjakob aninvestigationofthepredictorsofphotoprotectionanduvrdosetothefaceinpatientswithxpaprotocolusingobservationalmixedmethods
AT sniehottafalkof aninvestigationofthepredictorsofphotoprotectionanduvrdosetothefaceinpatientswithxpaprotocolusingobservationalmixedmethods
AT vieirarute aninvestigationofthepredictorsofphotoprotectionanduvrdosetothefaceinpatientswithxpaprotocolusingobservationalmixedmethods
AT wulfhanschristian aninvestigationofthepredictorsofphotoprotectionanduvrdosetothefaceinpatientswithxpaprotocolusingobservationalmixedmethods
AT weinmanjohn aninvestigationofthepredictorsofphotoprotectionanduvrdosetothefaceinpatientswithxpaprotocolusingobservationalmixedmethods
AT walburnjessica investigationofthepredictorsofphotoprotectionanduvrdosetothefaceinpatientswithxpaprotocolusingobservationalmixedmethods
AT sarkanyrobert investigationofthepredictorsofphotoprotectionanduvrdosetothefaceinpatientswithxpaprotocolusingobservationalmixedmethods
AT nortonsam investigationofthepredictorsofphotoprotectionanduvrdosetothefaceinpatientswithxpaprotocolusingobservationalmixedmethods
AT fosterlesley investigationofthepredictorsofphotoprotectionanduvrdosetothefaceinpatientswithxpaprotocolusingobservationalmixedmethods
AT morganmyfanwy investigationofthepredictorsofphotoprotectionanduvrdosetothefaceinpatientswithxpaprotocolusingobservationalmixedmethods
AT sainsburykirby investigationofthepredictorsofphotoprotectionanduvrdosetothefaceinpatientswithxpaprotocolusingobservationalmixedmethods
AT araujosoaresvera investigationofthepredictorsofphotoprotectionanduvrdosetothefaceinpatientswithxpaprotocolusingobservationalmixedmethods
AT andersonrebecca investigationofthepredictorsofphotoprotectionanduvrdosetothefaceinpatientswithxpaprotocolusingobservationalmixedmethods
AT garroodisabel investigationofthepredictorsofphotoprotectionanduvrdosetothefaceinpatientswithxpaprotocolusingobservationalmixedmethods
AT heydenreichjakob investigationofthepredictorsofphotoprotectionanduvrdosetothefaceinpatientswithxpaprotocolusingobservationalmixedmethods
AT sniehottafalkof investigationofthepredictorsofphotoprotectionanduvrdosetothefaceinpatientswithxpaprotocolusingobservationalmixedmethods
AT vieirarute investigationofthepredictorsofphotoprotectionanduvrdosetothefaceinpatientswithxpaprotocolusingobservationalmixedmethods
AT wulfhanschristian investigationofthepredictorsofphotoprotectionanduvrdosetothefaceinpatientswithxpaprotocolusingobservationalmixedmethods
AT weinmanjohn investigationofthepredictorsofphotoprotectionanduvrdosetothefaceinpatientswithxpaprotocolusingobservationalmixedmethods